What's New on the FDA Drugs Site
November 13, 2013
New and Generic Drug Approvals
November 12, 2013
Drug Name | Active Ingredient | Dosage Form/Route | Sponsor | Submission Type |
Actoplus Met XR | metformin hydrochloride; pioglitazone hydrochloride | Tablet, Extended Release;Oral | Takeda Pharms USA | Labeling Revision |
Actos | pioglitazone hydrochloride | Tablet;Oral | Takeda Pharms USA | Labeling Revision |
Duetact | glimepiride; pioglitazone hydrochloride | Tablet;Oral | Takeda Pharms USA | Labeling Revision |
Methylphenidate Hydrochloride | methylphenidate hydrochloride | Solution;Oral | Caraco | Approval |
Mozobil | plerixafor | Solution;Subcutaneous | Genzyme | Manufacturing Change or Addition |
Octreotide Acetate | octreotide acetate | Injectable;Injection | Sagent Pharms | Approval |
Octreotide Acetate (Preservative Free) | octreotide acetate | Injectable;Injection | Sagent Pharms | Approval |
Valstar Preservative Free | valrubicin | Solution;Intravesical | Endo Pharm | Manufacturing Change or Addition |
This email was sent to aqeel.naseem87.Aqeel7879598@blogger.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 | |